Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Kristine Paridaens"'
Publikováno v:
Frontiers in Gastroenterology, Vol 3 (2024)
Mesalazine is an established and recommended first-line treatment for mild-to-moderate ulcerative colitis (UC). For patients with moderately active UC, the choice to use mesalazine or to initiate treatment with an oral corticosteroid or anti-tumor ne
Externí odkaz:
https://doaj.org/article/4c8f9a2c11b64d4db6512b01305507f2
Publikováno v:
Gastroenterology Review, Vol 18, Iss 2, Pp 154-160 (2023)
Externí odkaz:
https://doaj.org/article/c36b9077bfc44d8b804f41e1a4ff4301
Publikováno v:
JGH Open, Vol 7, Iss 7, Pp 516-519 (2023)
Externí odkaz:
https://doaj.org/article/da17ca1aa4944eb6a8833ba2c0e978d5
Autor:
Ferdinando D’Amico, Vipul Jairath, Kristine Paridaens, Laurent Peyrin-Biroulet, Silvio Danese
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 9, p 2510 (2024)
Background/Objectives: The treatment of patients with mild-to-moderate ulcerative colitis (UC) is challenging. Although there are commonly used guidelines, therapy optimization is not standardized. We conducted a survey to investigate the management
Externí odkaz:
https://doaj.org/article/e1a8fe40c02e4613ab1460b8a09b30e7
Autor:
Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, John R Fullarton, Edouard Louis, Fernando Magro, Juan Ricardo Marquez, Alexander R Moschen, Neeraj Narula, Grazyna Rydzewska, Axel U Dignass, Simon PL Travis
Publikováno v:
Intestinal Research, Vol 21, Iss 1, Pp 161-167 (2023)
Externí odkaz:
https://doaj.org/article/45e18b6b5d02455eb3a2bcf5242f9cab
Autor:
Tommaso Lorenzo Parigi, Sophie Vieujean, Kristine Paridaens, Kira Dalgaard, Laurent Peyrin-Biroulet, Silvio Danese
Publikováno v:
Microorganisms, Vol 11, Iss 11, p 2806 (2023)
The gut microbiota play a pivotal role in human health. Dysbiosis, alterations in microbiota composition and function, is associated with gastrointestinal disorders, including inflammatory bowel disease (IBD). This international survey aimed to asses
Externí odkaz:
https://doaj.org/article/1b65fffa7ca747b9936d2cff80b405df
Autor:
Ferdinando D’Amico, Fernando Magro, Benedicte Caron, Axel Dignass, Vipul Jairath, Ailsa Hart, Paulo Gustavo Kotze, Kristine Paridaens, Sameer Al Awadhi, Taku Kobayashi, Britta Siegmund, Laurent Peyrin-Biroulet, Silvio Danese
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 3, p 1142 (2023)
The i Support Therapy–Access to Rapid Treatment (iSTART) was an initiative to improve patient-centered management in mild-to-moderate ulcerative colitis (UC). Our aim was to update the iSTART recommendations in order to include fecal calprotectin (
Externí odkaz:
https://doaj.org/article/85172325774843589123656afd37a926
Autor:
Bénédicte Caron, Vipul Jairath, Ferdinando D’Amico, Sameer Al Awadhi, Axel Dignass, Ailsa L. Hart, Taku Kobayashi, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Kristine Paridaens, Silvio Danese, Laurent Peyrin-Biroulet
Publikováno v:
Medicina, Vol 59, Iss 1, p 183 (2023)
Background and Objectives: At present, there is no consensus definition of mild-to-moderate disease activity in patients with ulcerative colitis. The objective of the present study was to establish a reliable definition of mild-to-moderate disease ac
Externí odkaz:
https://doaj.org/article/7084dc964d414d2a925b15b511cafcce
Autor:
Fernando Magro, Jakob Begun, Edouard Louis, Simon PL Travis, Alexander R Moschen, Neeraj Narula, Grazyna Rydzewska, Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, Axel U Dignass, Juan Ricardo Márquez, Matthew J Freddi
Publikováno v:
BMJ Open Gastroenterology, Vol 9, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/1a9b8eff0f044c5cb9f5ed163c5fcf85
Autor:
Dorit Vedel Ankersen, Petra Weimers, Mette Bennedsen, Anne Birgitte Haaber, Eva Lund Fjordside, Moritz Emanuel Beber, Christian Lieven, Sanaz Saboori, Nicolai Vad, Terje Rannem, Dorte Marker, Kristine Paridaens, Suzanne Frahm, Lisbeth Jensen, Malte Rosager Hansen, Johan Burisch, Pia Munkholm
Publikováno v:
Journal of Medical Internet Research, Vol 23, Iss 12, p e30291 (2021)
BackgroundThe long-term management of irritable bowel syndrome (IBS) poses many challenges. In short-term studies, eHealth interventions have been demonstrated to be safe and practical for at-home monitoring of the effects of probiotic treatments and
Externí odkaz:
https://doaj.org/article/5d2448871feb412db1bba94bcb095b53